Efficacy and Safety of ABT-126 in Subjects with Mild-to-Moderate Alzheimer’s Disease on Stable Doses of Acetylcholinesterase Inhibitors: A Randomized, Double-Blind, Placebo-Controlled Study-Reference-Cited by-同舟云学术

Efficacy and Safety of ABT-126 in Subjects with Mild-to-Moderate Alzheimer’s Disease on Stable Doses of Acetylcholinesterase Inhibitors: A Randomized, Double-Blind, Placebo-Controlled Study

Published:2016-04-12 Issue:4 Volume:51 Page:1237-1247
ISSN:1387-2877
Container-title:Journal of Alzheimer's Disease
language:
Short-container-title:JAD

Author:

Florian Hana¹,Meier Andreas¹,Gauthier Serge²,Lipschitz Stanley³,Lin Yunzhi¹,Tang Qi¹,Othman Ahmed A.¹⁴,Robieson Weining Z.¹,Gault Laura M.¹

Affiliation:

1. AbbVie Inc., North Chicago, IL, USA

2. McGill University Research Center for Studies in Aging, McGill University, Montreal, Quebec, Canada

3. The Dr. Stanley Lipschitz Clinic, Rosebank, Johannesburg, South Africa

4. Department of Pharmaceutics, Faculty of Pharmacy, Cairo University, Cairo, Egypt

Publisher

IOS Press

Subject

Psychiatry and Mental health,Geriatrics and Gerontology,Clinical Psychology,General Medicine,General Neuroscience

Reference20 articles.

1. Targeting the nicotinic alpha7 acetylcholine receptor to enhance cognition in disease;Wallace;Biochem Pharmacol,2011

2. Alzheimer disease: Current concepts and emerging diagnostic and therapeutic strategies;Clark;Ann Intern Med,2003

3. Treatment of Alzheimer disease;Winslow;Am Fam Physician,2011

4. Nicotinic acetylcholine receptors: From basic science to therapeutics;Hurst;Pharmacol Ther,2013

5. Quantitative assessment of nicotinic acetylcholine receptor proteins in the cerebral cortex of Alzheimer patients;Burghaus;Brain Res Mol Brain Res,2000

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Systematic Review on Drugs Acting as Nicotinic Acetylcholine Receptor Agonists in the Treatment of Dementia;Cells;2024-01-26

2. Review on anti-alzheimer drug development: approaches, challenges and perspectives;RSC Advances;2024

3. Role of Calcium Modulation in the Pathophysiology and Treatment of Alzheimer’s Disease;International Journal of Molecular Sciences;2023-05-22

4. Advances in Alzheimer’s disease’s pharmacological treatment;Frontiers in Pharmacology;2023-01-26

5. Levodopa-Induced Dyskinesia in Parkinson’s Disease: Pathogenesis and Emerging Treatment Strategies;Cells;2022-11-23